EUGENIE S KLEINERMAN to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications EUGENIE S KLEINERMAN has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.066
-
Biologic response modifiers in pediatric cancer. Hematol Oncol Clin North Am. 2001 Aug; 15(4):723-40, ix.
Score: 0.040
-
Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide. Hematol Oncol Clin North Am. 1995 Aug; 9(4):927-38.
Score: 0.026